Drugs / Tegeline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00505648 | Jan 2008 → Jun 2010 | hypersensitivity reaction disease | University Hospital, Rouen | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tegeline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00505648 ↗ |
| Known as | Human Immunoglobulin | “Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)” NCT00505648 ↗ |
| Modality | Protein / enzyme biologic | “Tegeline® (Human Immunoglobulin)” NCT00505648 ↗ |
| Route | Intravenous | “2g/kg in IV” NCT00505648 ↗ |